Do SCN1A mutations protect from hippocampal sclerosis?
Stéphane
S
Auvin
Olivier
O
Dulac
Louis
L
Vallée
D000818:Animals; D002118:Calcium / Q000378:metabolism; D004252:DNA Mutational Analysis; D004831:Epilepsies, Myoclonic / Q000235:genetics* / Q000473:pathology; D005838:Genotype; D006624:Hippocampus / Q000473:pathology*; D006801:Humans; D007223:Infant; D051379:Mice; D008817:Mice, Mutant Strains; D016202:N-Methylaspartate / Q000502:physiology; D062550:NAV1.1 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins / Q000235:genetics*; D009474:Neurons / Q000473:pathology; D010641:Phenotype; D012598:Sclerosis; D003294:Seizures, Febrile / Q000235:genetics* / Q000473:pathology; D015222:Sodium Channels / Q000235:genetics*
D062550:NAV1.1 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins; C568242:SCN1A protein, human; C568249:Scn1a protein, mouse; D015222:Sodium Channels; D016202:N-Methylaspartate; D002118:Calcium